Results 131 to 140 of about 4,453 (214)

Dose-selection study of clobetasol propionate ophthalmic suspension that evaluated inflammation and pain after cataract surgery. [PDF]

J Cataract Refract Surg
Levenson J, Walters TR, Martel J, Wang L, Nunez DJ.   +4 more
europepmc   +1 more source

Emerging Trends in the Application of Nanosuspension-Based Biomaterials for Anticancer Drug Delivery. [PDF]

Int J Nanomedicine
Aldeeb MME, Wilar G, Suhandi C, Mohammed AFA, Mahmoud SA, Elamin KM, Wathoni N.   +6 more
europepmc   +1 more source

Recent Advances in Glimepiride Solubility Improvement: A Focus on Formulation Technologies - A Narrative Review. [PDF]

Int J Nanomedicine
Fiftianingrum V, Sopyan I, Megantara S, Suhandi C.   +3 more
europepmc   +1 more source

Enhanced antitumour efficacy of ferulic acid nanoparticles in combination with doxorubicin - a promising strategy for breast cancer treatment. [PDF]

Contemp Oncol (Pozn)
Salama AF, Omran GA, Salahuddin AM, Abd-El-Azim HM, Noreldin A, Okda TM.   +5 more
europepmc   +1 more source

Enhancing Parenteral Nutrition via Supplementation with Antioxidant Lutein in Human Serum Albumin-Based Nanosuspension. [PDF]

Pharmaceutics
Żółnowska I, Gostyńska-Stawna A, Dominiak K, Jadach B, Stawny M.   +4 more
europepmc   +1 more source

Enhanced Everolimus Delivery: Development and Evaluation of a Nanosuspension Formulation. [PDF]

Int J Nanomedicine
Zeng Q, Chen J, Zhang H, Yu W, Xu H, Wang Q, Tang Z.   +6 more
europepmc   +1 more source

Erratum: Clinical, Biochemical and Molecular Evaluations of Ivermectin Mucoadhesive Nanosuspension Nasal Spray in Reducing Upper Respiratory Symptoms of Mild COVID-19 [Corrigendum]. [PDF]

Int J Nanomedicine
europepmc   +1 more source

Formulation and Characterization of <i>Sonchus arvensis</i> L. Nanosuspension for Enhanced Antioxidant and Lipid-Lowering Activities. [PDF]

Int J Nanomedicine
Aldeeb MME, Wilar G, Suhandi C, Mohammed AFA, El-Rayyes A, Elamin KM, Wathoni N.   +6 more
europepmc   +1 more source

Comparison of the pharmacokinetic profiles of three triterpenoids after oral administration of a cucurbitacin tablet and nanosuspension by UHPLC-MS/MS. [PDF]

Front Pharmacol
Zhang CN, Wang ZB, Du RT, Zhang SL, Wang CQ, Wang M, Wu LH, Yang DQ, Wang C.   +8 more
europepmc   +1 more source

Improving oral bioavailability of acalabrutinib using polymer-lipid hybrid nanoparticles: design, optimization, and <i>in vivo</i> pharmacokinetic evaluation. [PDF]

Nanoscale Adv
Sinha S, Ravi PR, Rashmi SR, Devaraju LK.   +3 more
europepmc   +1 more source